News|Articles|May 26, 2005

FDA Drug Safety Oversight Board

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Bristol Myers Squibb announced plans to expand its computing infrastructure collaboration with NVIDIA

Everything to know about BMS & NVidia’s AI Supercomputer

ByZachary Zubulake

July 20th 2026

PharmTech Weekly Roundup—July 17, 2026

BySusan Haigney

July 20th 2026

Midyear 2026 Check-In: Agentic AI Cuts Deviation Investigations by 50%

ByMegha Sinha,Zachary Zubulake

July 17th 2026

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

ByBrian Drapeau

July 16th 2026

Topical Corticosteroid Bioequivalence Guidance Ends 30-Year Wait

The Implications of the FDA’s New Finalized Guidance Documents

ByZachary Zubulake

July 16th 2026

FDA Drug Safety Oversight Board

Related Content

Everything to know about BMS & NVidia’s AI Supercomputer

PharmTech Weekly Roundup—July 17, 2026

Midyear 2026 Check-In: Agentic AI Cuts Deviation Investigations by 50%

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

The Implications of the FDA’s New Finalized Guidance Documents

Trending on Pharmaceutical Technology

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory

Can AI Fix Pharma's Last-Mile Delivery Blind Spot?

The Implications of the FDA’s New Finalized Guidance Documents

Everything to know about BMS & NVidia’s AI Supercomputer